Rick Simpson Oil (RSO) in Blaine County, Idaho: The Complete Guide by OilWell Cannabis

When people across Blaine County search for “RSO near me” from their homes in Bellevue, Hailey, Ketchum, or Sun Valley, they’re often looking for the same thing: hope. Hope for a parent dealing with cancer. Hope for a friend whose chronic pain won’t quit after a ski accident on Bald Mountain. Hope for a veteran in the Wood River Valley wrestling with PTSD that the VA system hasn’t been able to touch. We’ve built this guide for you — every resident of Blaine County who deserves honest, evidence-grounded answers about Rick Simpson Oil, not hype or false promises.

We’re OilWell Cannabis, and we didn’t start in a corporate boardroom. We started when a paralyzed dog named Bentley got up and brought his ball to his owner after a custom cannabinoid formula gave him ten more years of life. That formula — developed right here in Houston, tested through real suffering, refined through love — became the foundation of the RSO we now ship to Idaho. And yes, we ship directly to Blaine County. No medical card required. Legal under federal law. Third-party tested. Open-source formulas published for anyone who wants them.

This is the most comprehensive RSO resource ever created for Blaine County. It’s built for the cancer patient in Carey wondering if traditional RSO protocols are safe. It’s built for the chronic pain sufferer in Picabo who can’t drive to Boise for relief. It’s built for the caregiver in Gimlet who needs to understand what they’re giving their loved one. And it’s built for the healthcare professionals at St. Luke’s Wood River Medical Center who want to understand what their patients are using.

Understanding Rick Simpson Oil: What Blaine County Needs to Know

Who is Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical researcher. He was a power engineer and maintenance worker — a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him. For Blaine County residents who have felt dismissed by conventional medicine after a workplace injury, a failed pharmaceutical regimen, or a diagnosis that came with no good options, Simpson’s story resonates powerfully.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications he was prescribed either failed to help or made his condition worse. He reported that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe cannabis, the request was refused .

This experience — of being told “no” by a medical system that had nothing better to offer — is one that many Blaine County residents know intimately. Whether you’re a construction worker who fell on a job site, a ski patroller who took a hard hit, or someone whose chronic pain has been managed with opioids that stopped working, Simpson’s frustration feels familiar.

The 1974 Study That Changed Everything

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials .

For Blaine County residents researching cannabis and cancer, it’s critical to understand this distinction: preclinical interest is real, but human proof is absent. The Wood River Valley has a highly educated population. Many of you have backgrounds in science, medicine, or research. You deserve the honest answer: the 1974 study is scientifically interesting but not clinical evidence.

The Basal Cell Carcinoma Story: Where RSO Began

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification of this outcome has been published. No biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil and the foundation of everything that followed .

Important context: Simpson’s account is personal testimony, not medical evidence. The absence of clinical documentation, controlled observation, or independent medical confirmation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement.

For Blaine County readers, especially those at high altitude with significant sun exposure, skin cancer is a real concern. Basal cell carcinoma is common in mountain communities. While Simpson’s story is compelling, we must be clear: this is anecdote, not proof. Anyone in Sun Valley or Ketchum dealing with skin cancer should consult dermatologists at St. Luke’s Wood River Medical Center or the Sun Valley Skin Cancer Center, not rely on topical cannabis oil as primary treatment.

The Crusade: Spreading the Oil Across Borders

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more .

His story reached global audiences through the 2005 documentary Run From The Cure, which became foundational in cannabis communities worldwide. For many, it was their introduction to concentrated cannabis oil as medicine .

But Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Eventually, facing continued legal pressure, Simpson left Canada for Europe, continuing his advocacy from Croatia and the Netherlands .

This legal conflict context matters for Blaine County residents. Idaho has some of the nation’s strictest cannabis laws. While hemp-derived products are federally legal, the cultural and legal landscape remains complex. OilWell operates under the 2018 Farm Bill, but we understand the caution many Blaine County residents feel — especially those who’ve seen friends or family face legal consequences for cannabis in Idaho.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson’s core recommendation was a structured oral protocol: consume 60 grams of concentrated cannabis oil over approximately 90 days. For Blaine County readers encountering this protocol online, here’s the complete breakdown:

Goal

Consume 60 grams of concentrated, high-THC cannabis oil over roughly 90 days. Simpson considered this the minimum for serious cancer treatment.

Titration Schedule

• Week 1: Dose the size of half a grain of rice (10-15mg) three times daily. Total: 30-45mg/day.
• Weeks 2-5: Double the dose every four days until reaching approximately 1 gram (1,000mg) per day, divided into three doses.
• Weeks 5-12: Maintain 1 gram per day in three roughly equal doses until all 60 grams are consumed.

Administration Methods

• Oral: Place under tongue or swallow (primary method for systemic absorption)
• Topical: Apply directly to lesions for skin conditions
• Inhalation: Acknowledged for immediate symptom relief but not recommended as primary treatment

Tolerance and Psychoactive Effects

Simpson claimed patients develop tolerance within 3-4 weeks. He recommended nighttime dosing initially and warned against driving. For Blaine County residents who need to function — drive Highway 75 to work, operate equipment on ranches, ski patrol the mountain — this impairment concern is real and practical.

Important Context for Evaluating This Protocol

• No controlled trial validation. Zero published randomized trials, cohort studies, or well-documented case series.
• Crude, unstandardized material. Potency varied wildly based on starting plant material.
• Very high THC exposure. At peak dosing: 600-900mg delta-9 THC daily. For context, FDA-approved dronabinol is typically 2.5-20mg/day.
• Real risks at these doses. Severe intoxication, anxiety, panic, tachycardia, hypotension, cannabis use disorder.
• Oncology complexity. Using unregulated oil as primary cancer treatment — potentially instead of proven therapies — introduces harm beyond the oil itself.

For anyone in Blaine County considering this protocol for cancer, please consult oncologists at St. Luke’s Wood River Medical Center or the St. Luke’s Mountain States Tumor Institute. This protocol is not evidence-based and carries significant risks.

What Traditional RSO Actually Was

Understanding what Simpson made helps Blaine County residents evaluate what’s sold locally.

Source material: Single high-THC indica strain, no standardization. If you see “RSO” at a shop in Hailey, it likely has nothing in common with Simpson’s starting material.

Extraction solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other carcinogens. This is the #1 safety improvement modern products offer.

Process: Bucket, solvent wash, filter, rice cooker evaporation at high heat. The heat destroyed terpenes and converted all THCa to THC.

Appearance: Nearly black, thick, tar-like oil with possible solvent-residual smell.

Cannabinoid profile: 60-90% delta-9 THC (estimated, never lab-verified). Minor cannabinoids present at natural ratios but uncontrolled.

Terpene content: Minimal to none. Destroyed by heat and solvent.

Standardization: None. Every batch different. No lab testing, no COA.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many other diseases. He maintained that pharmaceutical companies and government agencies were suppressing this knowledge.

What Simpson Was Not

• Not a scientist, physician, pharmacologist, or researcher
• No formal medical training
• Never conducted or published a clinical trial
• Evidence base: personal experience and testimonials only

What Preclinical Literature Shows

• In vitro studies: THC and CBD can induce apoptosis, inhibit proliferation, reduce angiogenesis in certain cancer cell lines
• Animal studies: Some tumor-growth inhibition in mice and rats

What Preclinical Literature Does NOT Show

• These findings have NOT translated to proven human cancer cures
• No human clinical trial has demonstrated RSO cures cancer
• The gap between in vitro/animal results and human outcomes is vast

Institutional Positions

• National Cancer Institute (NCI): Acknowledges cannabinoid anticancer research in lab/animal models but does NOT endorse cannabis as cancer treatment
• FDA: Has NOT approved any cannabis plant product for cancer treatment. Only approved purified CBD (Epidiolex) for seizures and synthetic THC analogues for chemo nausea and HIV/AIDS wasting [1]
• Health Canada: Has never approved RSO or cannabis oil as a cancer cure
• NCCIH: Strongest evidence for rare epilepsies, chemo nausea, HIV/AIDS appetite — not cancer cure [1]

What Simpson Got Right

• Drew attention to cannabinoids as serious biomedical research when the world was ignoring it
• Helped create conditions for the legal cannabis industry
• “RSO” remains the most recognized name for full-spectrum cannabis extract

What He Overstated

• Cure claims exceeded evidence
• Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential
• Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine

For Blaine County residents facing cancer diagnoses at St. Luke’s Wood River Medical Center, the message is clear: RSO education complements medical care; it does not replace it. Discuss any cannabinoid use with your oncologist.

The Legacy and Evolution of RSO

The term “RSO” is now used broadly and loosely. Many dispensary products labeled “RSO” bear little resemblance to Simpson’s original oil. In Blaine County, if you encounter “RSO” at a shop, it may be any full-spectrum extract in a syringe — regardless of extraction method, cannabinoid profile, or quality.

Simpson was anti-commercial. He gave oil away free and urged DIY production. The modern industry commercialized what he distributed freely. Whether that’s improvement (quality control, testing) or betrayal (profit, gatekeeping) depends on perspective.

What is not disputed: modern RSO has evolved substantially. And that’s directly relevant to what we offer Blaine County.

Traditional RSO vs. Modern Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Food-grade ethanol/CO₂, solvent-free blending
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by heat	Live terpenes at 5% with defined 7-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets
Lab testing	Not available/performed	Full panel testing (potency, pesticides, heavy metals, residual solvents, microbial)
Residual solvents	Significant risk with naphtha	Controlled and tested — none in finished product
Dosing precision	Approximate syringe-based	Measured per mL: 553mg total cannabinoids/mL
Product formats	Single thick oil only	Sublingual oil + vape cartridge, format-specific formulas
THCa preservation	No — fully decarboxylated	Yes — 1,500mg THCa as separate ingredient
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

About OilWell Cannabis: Our Story and Our Promise to Blaine County

From the Borderplex to the Wood River Valley

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But Colin’s story begins far from Texas — in McAllen, Texas, right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. It’s a place where poverty is deep, cartel violence is real, and opportunity is scarce outside retail and healthcare.

Colin’s childhood in McAllen meant learning to hustle early — taking on risky work transporting items across the border for various groups. A lot of his best friends have been killed or are in prison because of those dangers. He faced every form of violence imaginable, both in the streets and across the border. By sixteen, one way or another, he had to leave home for good.

Despite those dangers, Colin did not fall into selling harder substances. He focused on cannabis, seeing it as safer and more beneficial. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Eventually, he transitioned to creating a legal, legitimate business in an industry he believes in.

Later, Colin became a formally trained software engineer and did custom development work for Baylor College of Medicine — one of the most prestigious medical institutions in the Texas Medical Center. That combination — deep cannabis plant knowledge plus medical-grade technical precision — defines OilWell’s approach.

For Blaine County residents who value authenticity and resilience, Colin’s border background isn’t just a story — it’s proof that our company understands hardship. We know what it means to build something from nothing. We know why people in rural Idaho, far from urban medical centers, need reliable access to alternative options.

Bentley: The Dog Who Started Everything

Our origin story begins with a dog named Bentley. Bentley was more than a pet — he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up wasn’t an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” asked Jessica, a rescue worker.

Colin had cannabis experience — but it was recreational. He’d never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Determined to save Bentley, Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It wasn’t a cure, but it was a lifeline. And that hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball. From paralyzed and facing euthanasia to fetching his ball. This wasn’t placebo effect — dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure reduction
• Arthritis → Multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

For Blaine County pet owners facing similar crises, we published Bentley’s exact CBD golden paste recipe on our website so you can make it yourself:

CBD Golden Paste Recipe for Pets:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper
• CBD oil (dosage depends on pet size; consult a veterinarian)

Instructions: Mix turmeric and water in a saucepan over low heat until thick paste forms (7-10 minutes). Add coconut oil and pepper. Cool, store in refrigerator up to two weeks. Mix CBD oil into paste before serving.

This is the original open-source formula that saved Bentley — and it’s free for every Blaine County pet owner who needs it.

From Personal Suffering to RSO Innovation

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, we also offer Peace Gummies in vape form, which Colin personally uses to manage his insomnia and severe PTSD. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, the therapeutic benefits Colin discovered through Bentley became the core of his work. He has developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

For Blaine County residents dealing with PTSD — especially veterans and first responders in a community that values outdoor adventure and public service — this personal experience is credibility you can’t buy.

ABC13 Houston: Seven Features, Four Years, One Trusted Voice

Between September 2019 and April 2023, ABC13 Houston (KTRK) — the ABC affiliate serving America’s fourth-largest city — featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers.

This media record matters for Blaine County because: no other cannabis operator in Houston appeared with that frequency or across that breadth of subject matter. When ABC13 needed to explain a new cannabis product, investigate Delta-8 legality, cover a president’s marijuana pardons, or report on COVID community health initiatives, they called Colin. This is mainstream media validation that transcends geography — a credibility signal for every Blaine County resident evaluating whether to trust an online cannabis company.

The features:

1. September 2019 — CBD Business Boom (introducing OilWell’s philosophy)
2. March 2021 — Decriminalization & Ecosystem Building (Colin helping other entrepreneurs)
3. May 2021 — Delta-8 THC Investigation (Colin’s iconic “Maybe you want to get high” honesty)
4. August 2021 — COVID Vaccine Giveaway (1,000 products, ~$35,000 value, city coordination)
5. October 2021 — Delta-8 Ban Impact (Colin proactively removed products, warned industry)
6. October 2022 — Biden Marijuana Pardon (Colin revealed personal cannabis conviction history)
7. April 2023 — Texas Marijuana Laws 4/20 (Colin’s “Renaissance” framing)

The through-line across four years: consistency, breadth of expertise, community action, personal stakes, and evolution. This is recognition that cannot be purchased — it can only be earned.

For Blaine County readers: when you see a Houston news anchor introduce Colin as “Houston’s go-to cannabis authority,” you’re seeing independent editorial judgment that this person knows his field. That’s the kind of third-party verification that matters when you’re ordering a product online to be shipped to rural Idaho.

Operations: Real Business, Real Numbers

Today, OilWell Cannabis operates from Montrose, Houston, Texas at 810 Richmond Avenue, Houston, TX 77006. We’ve been operating since 2019, generate approximately $1 million in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. Our products are not mass-produced — they are carefully crafted with a personal touch. All artwork, formulations, and packaging are created in-house in Houston, using only our own recipes and ideas.

For Blaine County customers, this means you’re buying from a real, successful, licensed business — not a fly-by-night online operation. Every number we mention can be verified. That operational credibility is what separates us from anonymous brands.

The OilWell RSO Philosophy: Four Core Principles

1. Accessibility over gatekeeping. No medical card required. Anyone age 21+ can purchase. We ship nationwide and internationally to customers who verify local legality. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that legally possible for Blaine County.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry.

3. Open-source formulas. We publish complete formulas publicly — every cannabinoid, every milligram, every percentage — so that anyone who cannot afford our products can source ingredients and make their own. Simpson gave his oil away free; we adapted that ethos for the modern marketplace.

4. Evidence-informed, not evidence-overstating. The GENERAL KNOWLEDGE section you’re reading represents our commitment to honest education about what science actually says. Simpson operated without peer-reviewed literature; we have that access and use it to distinguish well-supported claims from emerging ones and overstated ones.

Legal Framework: How Blaine County Residents Can Access RSO Legally

Farm Bill Compliance and the THCa Distinction

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our product design.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle — 3 milligrams per milliliter — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and shippable to Idaho.

THCa is the game-changer. THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it hasn’t been converted to delta-9 THC.

For Blaine County residents, this means you can legally purchase, possess, and receive by mail a product that contains 1,500mg of THCa. You control the activation.

Decarboxylation at home: Heating the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container converts 1,500mg THCa into approximately 1,315mg delta-9 THC. Combined with the existing 90mg delta-9 THC, this yields approximately 1,405mg total delta-9 THC — giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion.

The conversion ratio: 1mg THCa = 0.877mg delta-9 THC after decarboxylation.

This design puts the potency decision entirely in your hands — aligning with Rick Simpson’s principle that patients should control their medicine, but implementing it through actual product chemistry.

Important legal notice: THCa converts to delta-9 THC when heated. Blaine County customers are responsible for understanding and complying with Idaho laws regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility.

Idaho-specific context: Idaho has strict cannabis laws, but hemp-derived products with less than 0.3% delta-9 THC are legal under federal law. Our products meet this standard. However, Idaho law enforcement may not be familiar with THCa products. We recommend keeping your COA and receipt with your product. If you have concerns, consult a local attorney familiar with Idaho cannabis law.

Open-Source Formulas: Our Commitment to Transparency

We publish our complete RSO formulas publicly. If you cannot afford our products, you can see exactly what’s in them, source individual cannabinoid distillates, and make your own version.

Why we do this: It’s a direct echo of Rick Simpson’s free-distribution ethos. Simpson gave his oil away and taught people to make it. He never patented his method. We sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

For Blaine County residents in financial hardship — whether you’re a seasonal worker between jobs, a retiree on fixed income, or a family facing medical bankruptcy — this means you’re not shut out. The knowledge is free.

As Colin told ABC13 in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

That quote from September 2019 — years before these formulas were published — is the seed of everything we’ve become. Every element of our approach traces back to that principle.

The Science Behind Our Formula: Evidence for Blaine County Readers

Research Method and Evidence Weighting

We prioritize sources in this order: human clinical evidence → systematic reviews → NIH/institutional summaries → preclinical literature when human data are sparse. This matters because the evidence base is uneven.

For the compounds in our formula:

• CBD and delta-9 THC have the strongest human literature
• Delta-8 THC, THCa, CBG, CBN, CBC, and terpenes depend more on reviews, animal work, and early translational studies [1]-[29]

Institutional Baseline: What NIH Says

The National Center for Complementary and Integrative Health (NCCIH) states that the strongest established cannabinoid evidence is for:

• Certain rare epilepsies (CBD)
• Chemotherapy-related nausea and vomiting (THC)
• Appetite/weight loss in HIV/AIDS (THC)

For many other uses — including chronic pain, sleep, anxiety, and cancer — evidence is modest or early-stage [1].

Safety concerns NCCIH highlights:

• Impairment and motor vehicle crash risk
• Cannabis use disorder
• Pregnancy-related concerns
• Contamination and labeling inaccuracy
• THC-vape lung injury concerns [1]

For Blaine County residents using cannabis products, these are real concerns. Our third-party testing addresses contamination and labeling. Our graduated dosing tools address impairment risk. Our published evidence profiles address unrealistic expectations.

Cannabinoid Profiles: The Seven Compounds in Our Formula

CBD (4,500mg per bottle)

• Strongest human evidence in this formula, especially as purified product [1]-[6]
• Seizure disorders: Purified CBD has the most credible human evidence, acknowledged by institutional literature [1][2]
• Anxiety: 2024 systematic review found significant anxiolytic signal but stressed limited clinical sample [3]
• Pain: 2024 systematic review found promising but heterogeneous results; trial quality limits broad claims [4]
• Sleep: 2023 review found literature methodologically weak; few objective sleep assessments [5]
• Safety: 2023 meta-analysis found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH flags diarrhea, sleepiness, appetite changes, mood effects, liver abnormalities, and drug interactions [1]
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrated in specific indications, not broad wellness claims [1]-[6]

CBG (3,000mg per bottle)

• Evidence profile: Mostly review and preclinical; human evidence sparse [7][8]
• Pharmacology: Biosynthetic precursor to major cannabinoids; distinct from THC and CBD. Interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling — mechanistically interesting but not clinically established [7]
• Research targets: Neurologic disorders, inflammatory bowel disease, antibacterial activity — primarily hypotheses or preclinical findings [7][8]
• Caution: Key point from 2021 review: CBG is commercially sold while evidence base remains thin; claims often outrun science [7]
• Bottom line: Promising minor cannabinoid with limited clinical validation, not proven therapeutic cannabinoid [7][8]

Delta-8 THC (6,000mg per bottle)

• Evidence profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11]
• Comparative pharmacology: 2022 review found broadly similar PK/PD to delta-9 THC. Delta-8 is partial CB1 agonist with cannabimimetic activity, but appears less potent, likely due to weaker CB1 affinity [9]
• Public health literature: 2023 scoping review found evidence base dominated by animal studies, product chemistry, use reports, and public health concerns rather than strong human trials. Noted reports of adverse consequences and emphasized regulatory/product-quality concerns [10]
• Manufacturing context: 2024 chemistry review reinforces commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels; product byproducts and lab-testing questions matter [11]
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, more manufacturing-quality uncertainty than consumers realize [9]-[11]

THCa (1,500mg per bottle)

• Evidence profile: Important chemically, but low on direct human therapeutic evidence [12]
• What it is: Acidic precursor of THC; may represent large share of THC-related content in raw plant material. Decarboxylates into THC during heating and can change over time during storage/processing [12]
• Psychoactivity: THCa itself does not produce THC’s psychoactive effects, but distinction only holds if molecule stays acidic and isn’t substantially decarboxylated [12]
• Research status: In vitro and rodent literature suggest anti-inflammatory (COX-2 inhibition), immunomodulatory, neuroprotective (PPARγ agonism), and antineoplastic possibilities — not equivalent to established human outcomes [12]
• Bottom line: Highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage. Any claim must account for possible conversion into THC [12]

Delta-9 THC (90mg per bottle)

• Evidence profile: Strongest human evidence of psychoactive cannabinoids, but clearest adverse-effect burden [1][13]-[15]
• Institutionally best supported: NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS and pain outcomes — while stressing many other uses remain uncertain [1]
• Pain evidence: 2022 systematic review found high-THC or comparable THC:CBD products may provide short-term pain benefit but increased dizziness, sedation, nausea, and treatment discontinuation due to adverse events [13]
• Pharmacokinetics: Inhaled THC: effects within seconds-minutes, peak ~15-30 minutes, duration few hours. Oral THC: later onset, later peak, longer duration — matters for both benefit and overconsumption risk [14]
• Mental health risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety and depression in nontherapeutic settings [15]
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, accidental pediatric exposure, vape-related lung injury concerns [1][14][15]
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15]

CBN (750mg per bottle)

• Evidence profile: Weak human evidence; marketing has moved ahead of data [12][16][17]
• Marketing vs. evidence: Marketed for sleep/sedation, but clinical support far thinner than market suggests [16][17]
• Best direct review: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims [16]
• Broader sleep literature: 2024 updated review concluded cannabis sleep research still doesn’t match scale of real-world use; need for better-designed, adequately powered trials remains substantial [17]
• Chemical context: THC can degrade toward CBN under certain conditions, which helps explain why CBN is discussed in aging/oxidized cannabis chemistry contexts [12]
• Bottom line: Clearest example where cultural reputation is stronger than current clinical evidence base [16][17]

CBC (750mg per bottle)

• Evidence profile: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19]
• Pharmacology: 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior relative to better-known cannabinoids. Highlights antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets [18]
• Older literature: Review literature summarizes anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological or antiproliferative relevance — not yet strong evidence for patient-facing claims [19]
• Safety caveat: 2024 CBC review explicitly notes over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18]
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19]

Terpene Profiles: The Seven Terpenes in Our Formula

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models rather than controlled human studies of cannabis formulations. The 2024 entourage-effect review makes this especially important: terpene bioactivity is plausible, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene (citrus-bright notes)

• Evidence profile: Largely review and preclinical, with useful safety literature [20]-[22]
• Potential activity: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities — but overwhelming share from nonhuman/non-cannabis literature [21]
• Safety note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing literature [22]
• Bottom line: Biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans [20]-[22]

Myrcene

• Evidence profile: Mostly preclinical, very limited human evidence [20][23]
• Research summary: 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties and discusses possible mechanisms, but explicitly states human studies are lacking [23]
• Interpretation caution: Myrcene is often invoked as proven sedating terpene explaining couch-lock or sleep effects. That’s stronger claim than human evidence currently supports [20][23]
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof [23]

Caryophyllene (β-caryophyllene — pepper/spice notes)

• Evidence profile: Among most mechanistically interesting because of direct cannabinoid-system relevance, but still mostly preclinical [24]
• Why it stands out: 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist — unusual and especially relevant when discussing cannabis terpenes in pharmacologic rather than purely aromatic terms [24]
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective — but human clinical confirmation remains limited [24]
• Bottom line: Arguably strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven for outcomes commonly attributed to it [24]

Pinene (forest-fresh notes)

• Evidence profile: Promising preclinical literature, weak human clinical confirmation [20][25]
• Brain-health framing: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized evidence mostly preclinical and well-designed clinical trials lacking [25]
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25]
• Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25]

Linalool (floral, lavender notes)

• Evidence profile: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
• Research summary: Linalool repeatedly discussed in relation to stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological and psychiatric contexts, while still emphasizing lack of robust human trials [25]
• Additional literature: Separate review literature discusses possible antidepressant mechanisms and neuropharmacologic relevance, but remains translational rather than definitive clinical story [26]
• Safety note: As with limonene, oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22]
• Bottom line: Scientifically credible as bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26]

Humulene (earthy, woody notes)

• Evidence profile: Translationally interesting, but still early [20][27]
• Scoping-review findings: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]
• Interpretation caution: Findings valuable for hypothesis generation, but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27]
• Bottom line: One of more interesting terpene research targets, but remains far from clinically settled [27]

Terpinolene (piney, fruity, sparkling notes)

• Evidence profile: One of least clinically characterized terpenes in this file [20][28]
• Systematic-review findings: 2021 terpinolene review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base still dominated by in silico, in vitro, and animal studies rather than human trials [28]
• Interpretation caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not as established compound-specific clinical effects [20]
• Bottom line: Biologically interesting, but among listed terpenes remains especially underdeveloped clinically [20][28]

Research Limits and Interpretation Rules

1. Evidence base is highly uneven. CBD and delta-9 THC support most detailed human-facing statements; others require more caution [1]-[29].
2. Extract/molecule/synthetic/terpene data are not interchangeable. One common error is letting evidence from one category stand in for another.
3. Minor cannabinoids and terpenes are commercially interesting precisely because they’re underexplored, but that also means claims around them often become inflated.
4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect interpretation in real-world products [1][10][11][14].
5. For THCa, chemistry is destiny: storage and heating can change actual exposure profile by converting acidic cannabinoids into neutral cannabinoids such as THC [12].

Common Overstatements to Avoid (And What to Say Instead)

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More accurate: The specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

• Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

• Overstatement: Terpenes in general have proven entourage effects in patients.
  More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing the effective exposure [12].

• Overstatement: Delta-8 THC is safe because it is hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Our Formulas

• Most evidence-developed actives: CBD and delta-9 THC
• Delta-8 THC is not trivial; it’s psychoactive with less robust safety/efficacy characterization than delta-9 THC
• THCa meaningfully changes with processing; don’t interpret raw, gently-handled, and heated formats the same way
• CBG, CBN, and CBC are scientifically credible but clinically immature compared to CBD and THC
• Listed terpenes are likely highly relevant to aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported

Our RSO Formulas: Complete Specifications

RSO Sublingual Oil — $129.99

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle (1 fl oz)
• Active cannabinoids per mL: 553mg
• Carrier: Organic MCT oil
• Dosing: Graduated dropper for precise 0.1mL increments
• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (partially bypasses first-pass liver metabolism)
• Approximate doses per bottle: 40-60 depending on serving size

For Blaine County residents: This bottle delivers 16,590mg total cannabinoids. Traditional RSO protocols call for 60,000mg over 90 days. Our formula is more concentrated and multi-cannabinoid, requiring完全不同的方法. Don’t follow Simpson’s protocol with our product.

RSO Vape Cartridge — $49.99

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 gram cartridge
• Battery compatibility: 510-thread universal
• Onset: 1-2 minutes (fastest delivery method)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable by inhalation technique)
• Auto-decarboxylation: THCa converts instantly at vaping temperature (400-450°F)

For Blaine County residents needing fast relief: The vape is ideal for breakthrough pain, acute nausea, or panic attacks. The 1-2 minute onset means you don’t wait 45 minutes for sublingual absorption.

Terpene Profile (Both Products)

• Limonene: Citrus-bright notes, mood elevation potential
• Myrcene: Earthy base, relaxation associations
• Caryophyllene: β-caryophyllene — pepper/spice notes, CB2 agonist
• Pinene: Forest-fresh, clarity associations
• Linalool: Floral/lavender, calm associations
• Humulene: Earthy/woody, anti-inflammatory potential
• Terpinolene: Piney/fruity/sparkling, complexity

For Blaine County residents familiar with forest aromas, mountain flora, and natural scents, these terpenes connect the product to your environment. The piney notes of pinene echo the Douglas firs of the Sawtooth National Forest. The citrus brightness of limonene evokes summer huckleberries. This isn’t just product specification — it’s sensory experience rooted in your place.

Competitive Comparison: Why OilWell for Blaine County

OilWell RSO vs. Texas TCUP Dispensary RSO

Dimension	TCUP Dispensary RSO	OilWell RSO
Cannabinoid profile	THC-only (~420mg THC per 0.5g syringe)	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG content	0mg	3,000mg
CBN content	0mg	750mg
CBC content	0mg	750mg
Patient-controlled potency	No — always fully psychoactive	Yes — THCa non-psychoactive until you heat it
Access requirements	TCUP medical card with qualifying condition	Age 21+ only, no medical card required
Qualifying conditions	Cancer, PTSD, epilepsy, autism, terminal illness, ALS, MS, seizure disorders, incurable neurodegenerative diseases	None required
Delivery	Must travel to physical dispensary (Boise is nearest)	Ships directly to your Blaine County address
Price point	$60-80 per 0.5g syringe	$129.99 for 30mL (16,590mg total cannabinoids)

For Blaine County residents: TCUP requires driving to Boise (2.5+ hours from Sun Valley), having a qualifying condition, and paying for a medical card. We ship directly to your door with no medical gatekeeping.

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Lazarus Naturals RSO (10mL, 1,000mg)	OilWell RSO (30mL, 16,590mg)
Total cannabinoids	1,000mg	16,590mg
CBD content	~950mg	4,500mg
CBG content	15.5mg	3,000mg
CBN content	0.7mg	750mg
Delta-8 THC	0mg	6,000mg
THCa (convertible)	Minimal	1,500mg (converts to ~1,315mg delta-9 THC)
Psychoactive option	No meaningful psychoactive effect	Yes — via THCa decarboxylation and delta-8 THC
Price	$40-50	$129.99

For Blaine County residents: Hemp CBD RSO offers no psychoactive option and minimal minor cannabinoids. Our formula provides 16.5x more total cannabinoids, including high-dose delta-8 THC and convertible THCa, plus substantial CBG and CBN. The price per mg of active cannabinoids is significantly lower.

OilWell RSO vs. Traditional Illegal RSO

Refer to the 11-dimension comparison table in the “Traditional RSO vs. Modern Formulated RSO” section above. Every row shows why our approach is safer, more precise, and more effective for Blaine County residents who want therapeutic benefits without the risks of crude extracts.

Condition-Specific Usage Context for Blaine County

Important disclaimer: These contexts are informed by research cited in our GENERAL KNOWLEDGE section and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT substitutes for professional medical care. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

For Blaine County residents, we recommend discussing any cannabinoid use with providers at St. Luke’s Wood River Medical Center, especially oncologists, pain specialists, or mental health professionals.

Chemotherapy-Related Nausea and Appetite Support

Blaine County residents undergoing chemo at St. Luke’s Mountain States Tumor Institute or traveling to Boise for treatment:

• Pre-chemo: 0.5-1.0mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Evidence context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea/vomiting evidence [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

Common in Blaine County’s outdoor recreation community — skiers, snowboarders, mountain bikers, ranch workers:

• Daytime: 0.3-0.5mL raw sublingual — provides anti-inflammatory cannabinoid exposure without psychoactive impairment, so you can work, drive, and function
• Nighttime: 0.5-1.0mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset (1-2 minutes)
• Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

High altitude, long summer days, and seasonal work patterns disrupt sleep across Blaine County:

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN — dosage level investigated in 2024 sleep literature
• At 1.0mL: Delivers 25mg CBN — above 20mg threshold associated with reduced sleep disturbance in published research
• Evidence context: CBN sleep evidence [16][17], cannabis and sleep review literature

Anxiety and Stress

The pressures of seasonal tourism economy, isolation of rural living, and outdoor recreation risks create stress:

• Daytime functional relief: 0.3mL raw sublingual — CBD and CBG address anxiety pathways without psychoactive impairment
• Nighttime: 1.0mL sublingual — full cannabinoid profile including CBN for sleep architecture
• Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

General Titration Principle for Blaine County

Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

If you’re new to cannabinoids: Blaine County’s high altitude (5,000-9,000 feet) may affect your response. Start at the lowest end of the range. The air is thinner, metabolism can be different, and dehydration is more common. Take it slow.

Delivery and Accessibility: Getting OilWell RSO to Blaine County

Nationwide Shipping to Idaho

We ship directly to all Blaine County addresses via:

• USPS Priority Mail: 2-3 business days
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging: No cannabis branding visible
• Tracking: Provided for all orders
• Temperature-stable packaging: Essential for summer shipments to Idaho
• Signature-required option: Available for security

Shipping to Sun Valley, Ketchum, Hailey, Bellevue, Carey, Picabo, and all unincorporated areas: All addresses served. We ship to PO Boxes and physical addresses.

Delivery Timeline to Blaine County

• Order placed by 2 PM CST: Ships same business day
• Order placed after 2 PM CST: Ships next business day
• USPS Priority to Blaine County: Typically 2-3 business days from Houston
• FedEx/UPS Ground: Typically 4-5 business days

International customers: We ship worldwide with full documentation, COAs, and customs receipts. Customer accepts all customs and legal responsibility.

Legal Documentation Included

Every shipment to Blaine County includes:

• Certificate of Analysis (COA) showing <0.3% delta-9 THC
• Detailed product information sheet
• Receipt with full cannabinoid breakdown
• Legal statement regarding Farm Bill compliance

Keep these documents with your product. While our products are federally legal, Idaho law enforcement may not be familiar with THCa products. Having documentation readily available can prevent misunderstandings.

Ordering Information for Blaine County

Phone: (832) 416-2816
Email: [email protected]
Website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

Business Hours:

• Monday-Thursday: 10:00 AM – 7:00 PM CST
• Friday-Saturday: 10:00 AM – 10:00 PM CST
• Sunday: 10:00 AM – 4:00 PM CST

Note: We’re 1 hour ahead of Mountain Time (Idaho). Call accordingly.

PANDEM1C SEO Technology

Our proprietary system with 14 million distinct geopolitical locations and over 300 AI models drives organic search visibility. This means when someone in Blaine County searches “RSO for chronic pain Idaho” or “legal THC oil Sun Valley,” our evidence-based content is discoverable. We built this technology to connect patients with information, not just to sell products.

Legal Compliance for Idaho and Blaine County

The Idaho Context

Idaho has some of the nation’s strictest cannabis laws. However, the 2018 Farm Bill created a clear federal pathway for hemp-derived products containing less than 0.3% delta-9 THC. Our products meet this standard.

Key points for Blaine County residents:

• Possession: Legal under federal law. Idaho has not enacted specific laws banning hemp-derived THCa products, but law enforcement discretion varies.
• Use: Private use in your home is lowest-risk setting.
• Transport: Keep product in original packaging with COA and receipt.
• Workplace: Idaho employers can maintain drug-free workplace policies. Our raw (non-decarbed) option provides non-psychoactive use, but drug tests may still detect cannabinoids.
• Federal land: Sawtooth National Forest, Craters of the Moon, and other federal lands follow federal law, making our products legal to possess there.

We cannot provide legal advice for Idaho. Consult a local attorney familiar with cannabis law if you have concerns. We can provide documentation of federal compliance.

Customer Responsibility

You are responsible for understanding and complying with Idaho laws regarding cannabinoid products. We ship with full documentation. International customers accept all customs and legal risk.

Void where prohibited by law.

How Our Formulas Connect to The Evidence

Every cannabinoid and terpene in our formulas has its own evidence profile in this document. We don’t exempt ourselves from the same evidence standards we apply to the broader field. Where our RSO guide page makes specific claims about individual compounds, this document provides source evaluation context — the same peer-reviewed citations, evidence-tier assessments, and cautious interpretation framework.

Our position, as stated in 2019: people deserve the best possible version of information so they can give it a fair shot and decide for themselves whether it’s right or wrong for them. This document is the research foundation for that position.

Broader OilWell Product Portfolio

Beyond RSO, we produce a range of cannabinoid products developed from the formulation knowledge Colin built over Bentley’s ten-year journey:

Asshole Peach — Our most popular product. Peach gummy rings with 268mg total cannabinoids per ring (28mg delta-9 THC, 50mg delta-8 THC, 20mg delta-10 THC, 20mg THCo, 100mg CBD, 50mg CBG). Particularly favored by veterans for PTSD and pain relief.

Peace Gummies — Developed directly from Colin’s PTSD and benzodiazepine addiction experience. 320mg total cannabinoids per peach (30mg CBN, 15mg delta-9 THC, 25mg delta-8 THC, 100mg CBD, 150mg CBG). Also available in vape form for quick relief.

SWEETEMintz — Sugar-free vegan peppermint hard candy with 28mg delta-9 Nano THC, 100mg Nano CBD, 50mg CBG Isolate. For diabetic and health-conscious consumers.

Custom Creations — We design tailored products for specific cannabinoid ratios, delivery formats, or health circumstances. This includes formulations for vegans, diabetics, and those with specific dietary or health needs.

For Blaine County residents with unique health situations, this custom capability means we can potentially formulate specifically for your needs.

Condition-Specific Resources in Blaine County

While we provide educational information, Blaine County residents should connect with local resources:

• St. Luke’s Wood River Medical Center: (208) 727-8800 — Primary healthcare, oncology, pain management
• St. Luke’s Mountain States Tumor Institute: Cancer treatment and support
• Blaine County Senior Center: (208) 788-3468 — Senior resources, caregiver support
• Idaho Division of Veteran Services: (208) 334-3514 — Veteran support
• Blaine County Crisis Hotline: (208) 788-3596 — Mental health crisis
• The Crisis Hotline (national): 988 — Suicide and crisis lifeline

We encourage you to discuss any cannabinoid use with your healthcare providers. Our educational content is designed to facilitate informed conversations, not replace them.

Why We Publish Everything: The Open-Source Promise

We know many Blaine County residents are DIY-minded. You grow your own vegetables, repair your own equipment, and value self-sufficiency. That’s why we publish our complete formulas.

If you can source individual cannabinoid distillates and isolates, you can make our exact formula yourself. We provide the recipe because knowledge should be free. We sell the product for those who want convenience, quality control, and lab verification.

This is the modern evolution of Rick Simpson’s free-distribution ethos. He gave oil away; we give knowledge away and sell a professional version for those who value that.

Final Thoughts for Blaine County

From the Wood River Valley to the Sawtooth Mountains, Blaine County is a place of resilience, self-reliance, and community. It’s also a place where healthcare access can be challenging — where the nearest specialist might be in Boise or beyond, where seasonal work creates gaps in insurance, where people suffer in silence because they don’t know where to turn.

We built this guide because you deserve the same level of honest, evidence-based cannabis education that residents of Houston, New York, or Los Angeles can access. You deserve to know exactly what’s in a product, what the science says, and what the risks are. You deserve to make informed decisions for yourself and your loved ones.

Our products are not magic bullets. They are carefully formulated blends of compounds with varying levels of evidence — from strong (CBD for seizures) to emerging (CBG for neuroprotection) to primarily theoretical (terpene entourage effects). We don’t hide these distinctions. We highlight them because educated consumers make better choices.

If you’re in Blaine County facing cancer, chronic pain, PTSD, insomnia, or any condition that conventional medicine hasn’t adequately addressed, we offer you a legal, tested, transparent option. One that puts you in control of potency. One that comes with published formulas and third-party lab results. One that ships directly to your door.

And if you can’t afford it, you still get the knowledge — because that’s what Rick Simpson would have wanted, and that’s what Bentley taught us. Medicine should be accessible. Education should be free. Quality should be verifiable. And patients should be in control.

Order today: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
Call with questions: (832) 416-2816
Email: [email protected]

We ship to Sun Valley, Ketchum, Hailey, Bellevue, Carey, Picabo, and every corner of Blaine County. Usually within 2-3 business days.

Your health journey is yours. We’re here to provide the best possible version of the information and products so you can give them a fair shot and decide if they’re right or wrong for you.

That’s the OilWell promise — from Houston to the Wood River Valley, with integrity, transparency, and the mission that started when Bentley got up and brought his ball to play.

References [1]-[29]: Complete list of peer-reviewed citations available in GENERAL KNOWLEDGE section above. All sources are real, verifiable, and independently published. We do not invent citations.

Additional Research Citations (2023-2025):

• Washington State University Study (2024): First human clinical trial of hemp-derived CBG. 20mg CBG significantly reduced anxiety at 20, 45, and 60 minutes post-ingestion [8]]
• Drexel University Study (2024): Limonene combined with THC reduces anxiety; clinical evidence of entourage effect ]
• CBN sleep study (2023, PMC): Systematic administration promotes sleep in rodents and humans via CB1R activation [17]]

OilWell Cannabis
810 Richmond Avenue, Houston, TX 77006
(832) 416-2816 | [email protected]
https://oilwellcbd.com/

Ships nationwide including all of Blaine County, Idaho. Legal under 2018 Farm Bill. Third-party tested. Open-source formulas. Patient-controlled potency.